Clinical Study
Effect of High-Dose Oral Rabeprazole on Recurrent Bleeding after Endoscopic Treatment of Bleeding Peptic Ulcers
Table 3
Outcomes in the study patients with a bleeding peptic ulcer (ITT population).
| | | Oral rabeprazole group () | IV omeprazole group () | value |
| | Rebleeding within 3 days | 2 | 1 | 1.000 | | Rebleeding after 3 days | 1 | 0 | 1.000 | | Total rebleeding | 3 | 1 | 0.618 | | Surgery | 2 | 0 | 0.495 | | Death | 1 | 0 | 1.000 | | Blood transfusion (units) | | | 0.582 | | Duration of hospitalization (days) | | | 0.124 |
|
|
ITT: intention-to-treat; IV: intravenous.
|
